Cargando…

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Janes, Holly, Frahm, Nicole, DeCamp, Allan, Rolland, Morgane, Gabriel, Erin, Wolfson, Julian, Hertz, Tomer, Kallas, Esper, Goepfert, Paul, Friedrich, David P., Corey, Lawrence, Mullins, James I., McElrath, M. Juliana, Gilbert, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428369/
https://www.ncbi.nlm.nih.gov/pubmed/22952672
http://dx.doi.org/10.1371/journal.pone.0043396
_version_ 1782241696411549696
author Janes, Holly
Frahm, Nicole
DeCamp, Allan
Rolland, Morgane
Gabriel, Erin
Wolfson, Julian
Hertz, Tomer
Kallas, Esper
Goepfert, Paul
Friedrich, David P.
Corey, Lawrence
Mullins, James I.
McElrath, M. Juliana
Gilbert, Peter
author_facet Janes, Holly
Frahm, Nicole
DeCamp, Allan
Rolland, Morgane
Gabriel, Erin
Wolfson, Julian
Hertz, Tomer
Kallas, Esper
Goepfert, Paul
Friedrich, David P.
Corey, Lawrence
Mullins, James I.
McElrath, M. Juliana
Gilbert, Peter
author_sort Janes, Holly
collection PubMed
description BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. METHODS: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. FINDINGS: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0·04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0·06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0·04; Pol p = 0·13; Gag p = 0·89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p>0·50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4·7 vs 5·1) but the difference was not significant (p = 0·27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0·30). INTERPRETATION: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.
format Online
Article
Text
id pubmed-3428369
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34283692012-09-05 MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load Janes, Holly Frahm, Nicole DeCamp, Allan Rolland, Morgane Gabriel, Erin Wolfson, Julian Hertz, Tomer Kallas, Esper Goepfert, Paul Friedrich, David P. Corey, Lawrence Mullins, James I. McElrath, M. Juliana Gilbert, Peter PLoS One Research Article BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. METHODS: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. FINDINGS: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0·04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0·06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0·04; Pol p = 0·13; Gag p = 0·89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p>0·50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4·7 vs 5·1) but the difference was not significant (p = 0·27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0·30). INTERPRETATION: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression. Public Library of Science 2012-08-27 /pmc/articles/PMC3428369/ /pubmed/22952672 http://dx.doi.org/10.1371/journal.pone.0043396 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Janes, Holly
Frahm, Nicole
DeCamp, Allan
Rolland, Morgane
Gabriel, Erin
Wolfson, Julian
Hertz, Tomer
Kallas, Esper
Goepfert, Paul
Friedrich, David P.
Corey, Lawrence
Mullins, James I.
McElrath, M. Juliana
Gilbert, Peter
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title_full MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title_fullStr MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title_full_unstemmed MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title_short MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
title_sort mrkad5 hiv-1 gag/pol/nef vaccine-induced t-cell responses inadequately predict distance of breakthrough hiv-1 sequences to the vaccine or viral load
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428369/
https://www.ncbi.nlm.nih.gov/pubmed/22952672
http://dx.doi.org/10.1371/journal.pone.0043396
work_keys_str_mv AT janesholly mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT frahmnicole mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT decampallan mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT rollandmorgane mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT gabrielerin mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT wolfsonjulian mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT hertztomer mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT kallasesper mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT goepfertpaul mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT friedrichdavidp mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT coreylawrence mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT mullinsjamesi mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT mcelrathmjuliana mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload
AT gilbertpeter mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload